NAM

NAM

Trading
18,234 Views
The NAM project is a project to combine artificial intelligence (AI) and block chain technology to bring about innovation in the Japanese medical system. <br /> NAM will solve problems using AI and block chains.
General
Website: Visit
White paper: Read
ICO Time: 29 Jan 2018 - 31 Mar 2018
Whitelist/KYC: KYC
Country: Hong Kong
Token info
Ticker: NAM
Platform: Ethereum
Token Type: ERC20
Available for sale: 60,000,000,000 NAM (50%)
Total supply: 120,000,000,000 NAM
Financial
ICO Price: β‰ˆ 0.006 USD
Screenshots taken on 8 Feb 2018
December 24, 2017 to January 31, 2018.
It is the stage that we make this project recognized and we will finance through ICO. For<br /> <br /> the investor, we will spread the project to provide various methods to buy NAM coin, to be sponsored widely, for anyone in the world to purchase coins.<br /> <br /> Specifically, it takes the form of remittance from each individual wallet to the project's wallet, exchanged with multi-currency (main virtual currency).
2018
Early<br /> <br /> Exchange listed.<br /> <br /> Launch of exchange-listed company's own service, Release of crowd-funding service.<br /> <br /> Late<br /> <br /> Start of test operation as settlement system Start full-scale operation of the system.
2019
Expansion of business.
Teppei Nakano
CEO
Participates in a number of projects
Yutaro Nakamura
COO
Participates in a number of projects
Zephyr Shu
Marketing Partner
Participates in a number of projects
Takuma Kuroha
CTO
Participates in a number of projects
Ken Yanagisawa
lawyer
Participates in a number of projects
Mr.vinh
Engineer
Participates in a number of projects
Mr.Nhat
Engineer
Participates in a number of projects
Mr.Ngoc
Engineer
Participates in a number of projects
Mr.Lan
Engineer
Participates in a number of projects

Advisors (0)

ICO List
Other Interesting ICOs
Upcoming
MeFy
Mefy works on a subscription-based model, where the user of MeMe Care subscribes for yearly subscription allowing them any number of tests throughout the year for the cost of just consumables. Through its eConsult feature it connects worldwide doctors to worldwide patients thereby resolving accessibility issues and with its MeMe Edge device, it provides authenticity to the test conducted.
Active
COTI
COTI is the world’s first blockchain protocol optimized for decentralized payments, designed for use by merchants, governments, payment dApps and stable coin issuers. COTI Pay, our first app, already boasts a network of 5,000 merchants and 80,000 users. COTI uses a DAG (directed acyclic graph) ledger to address the shortcomings of blockchain platforms that make them unsuitable for supporting mainstream and everyday transactional needs.
Upcoming
Pigzbe
Pigzbe uses the blockchain to make money transfers within families borderless, safe, and instant. By unlocking the potential of globalised families as micro-financing networks, Pigzbe teaches children about money in the 21st century.
Upcoming
ORCA Alliance
Control your money, savings and crypto assets from one application. Benefit from simple and intuitive user interface to manage your cash flows. ORCA Platform merges a variety of financial service providers. Access payment cards, lending services, make instant transactions to crypto wallets, exchanges and bank accounts.
Upcoming
Sponsy
Sponsy is disrupting the sponsorship industry. It is a one-stop online solution for sponsors and sponsees to conduct sponsorship deals. By tokenizing sponsorship assets and decentralizing decision-making, we do not only reduce costs, but also provide sponsees with a wider choice of sponsorship opportunities and make sponsorships available to every business.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.